[1]
Hafeez, M. et al. 2016. Clinical outcome of management of acute myeloid leukemia with idarubicin plus cytarabine. Annals of King Edward Medical University. 11, 4 (Apr. 2016). DOI:https://doi.org/10.21649/akemu.v11i4.1100.